{
    "title": "U.S. FDA approves UCB's drug for rare childhood epilepsy",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10658839/U-S-FDA-approves-UCBs-drug-rare-childhood-epilepsy.html",
    "date": "2022-03-28",
    "keywords": [
        "drug",
        "fintepla",
        "lgs",
        "approval",
        "zogenix",
        "indication",
        "biotech",
        "firm",
        "ucb",
        "form",
        "syndrome",
        "fda",
        "heart",
        "study",
        "reduction",
        "frequency",
        "march",
        "sa",
        "monday",
        "food",
        "administration",
        "childhood",
        "childhoodonset",
        "epilepsy",
        "dysfunction",
        "unit",
        "safety",
        "efficacy",
        "phase",
        "trial",
        "statement",
        "distribution",
        "program",
        "deal",
        "worth",
        "month",
        "analyst",
        "forecast",
        "worldwide",
        "receptor",
        "sigma",
        "brain",
        "warning",
        "lung",
        "disease",
        "hypertension",
        "jazz",
        "epidiolex",
        "latestage",
        "seizure",
        "period",
        "pricing",
        "use",
        "therapy",
        "kapadia",
        "ds",
        "product",
        "competition",
        "soticlestat",
        "cos",
        "lorcaserin",
        "fycompa",
        "reporting",
        "bhanvi",
        "satija",
        "manojna",
        "maddipatla",
        "bengaluru",
        "editing",
        "syamnath",
        "sherry",
        "subhranshu",
        "sahu"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}